Thermo Fisher Scientific Inc. (ETR:TN8)

Marinus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,576	4,009	8,077	8,524	4,477	10,325
Short-Term Investments	1,814	1,561	3	-	-	-
Cash & Short-Term Investments	6,390	5,570	8,080	8,524	4,477	10,325
Cash Growth	-27.58%	-31.06%	-5.21%	90.40%	-56.64%	330.39%
Accounts Receivable	10,035	9,626	9,664	9,427	8,945	6,472
Receivables	10,035	9,626	9,664	9,427	8,945	6,472
Inventory	5,559	4,978	5,088	5,634	5,051	4,029
Restricted Cash	3	10	6	12	13	10
Other Current Assets	2,597	1,953	1,751	1,632	1,627	1,121
Total Current Assets	24,584	22,137	24,589	25,229	20,113	21,957
Property, Plant & Equipment	9,635	10,795	11,004	10,873	9,864	6,687
Long-Term Investments	174	438	534	154	63	53
Goodwill	47,249	45,853	44,020	41,196	41,924	26,041
Other Intangible Assets	15,148	15,533	16,670	17,478	20,146	12,685
Long-Term Accounts Receivable	-	6	4	7	9	11
Other Long-Term Assets	4,440	2,559	1,905	2,217	3,004	1,618
Total Assets	101,230	97,321	98,726	97,154	95,123	69,052
Accounts Payable	2,980	3,079	2,872	3,381	2,867	2,175
Accrued Expenses	4,642	4,876	4,519	5,120	5,093	3,939
Short-Term Debt	-	-	-	310	2,522	-
Current Portion of Long-Term Debt	2,214	2,202	3,609	5,269	-	2,628
Current Portion of Leases	-	273	263	272	281	184
Current Unearned Revenue	2,805	2,852	2,689	2,601	2,655	1,271
Other Current Liabilities	77	50	60	57	18	107
Total Current Liabilities	12,718	13,332	14,012	17,010	13,436	10,304
Long-Term Debt	32,819	28,928	31,405	28,784	32,148	19,146
Long-Term Leases	196	1,429	1,434	1,523	1,388	633
Long-Term Unearned Revenue	-	1,138	1,499	1,179	1,238	763
Long-Term Deferred Tax Liabilities	624	1,268	1,922	2,849	3,837	1,794
Other Long-Term Liabilities	4,270	1,200	1,229	1,338	1,595	1,356
Total Liabilities	50,627	47,650	51,884	53,006	54,146	34,535
Common Stock	444	444	442	441	439	437
Additional Paid-In Capital	18,232	17,962	17,286	16,743	16,174	15,579
Retained Earnings	55,901	53,102	47,364	41,910	35,431	28,116
Treasury Stock	-21,269	-19,226	-15,133	-12,017	-8,922	-6,818
Comprehensive Income & Other	-2,796	-2,698	-3,224	-3,099	-2,329	-2,807
Total Common Equity	50,512	49,584	46,735	43,978	40,793	34,507
Minority Interest	91	87	107	170	184	10
Shareholders' Equity	50,603	49,671	46,842	44,148	40,977	34,517
Total Liabilities & Equity	101,230	97,321	98,726	97,154	95,123	69,052
Total Debt	35,229	32,832	36,711	36,158	36,339	22,591
Net Cash (Debt)	-28,839	-27,262	-28,631	-27,634	-31,862	-12,266
Net Cash Per Share	-75.79	-71.18	-73.79	-70.14	-80.26	-30.74
Filing Date Shares Outstanding	377.61	377.26	381.31	385.43	391.19	393.79
Total Common Shares Outstanding	377.61	380.77	386.65	390.51	394.43	396.67
Working Capital	11,866	8,805	10,577	8,219	6,677	11,653
Book Value Per Share	133.77	130.22	120.87	112.62	103.42	86.99
Tangible Book Value	-11,885	-11,802	-13,955	-14,696	-21,277	-4,219
Tangible Book Value Per Share	-31.47	-30.99	-36.09	-37.63	-53.94	-10.64
Land	-	439	458	454	431	410
Buildings	-	3,728	3,593	3,153	2,575	2,192
Machinery	-	9,858	9,235	7,967	7,020	6,975
Construction In Progress	-	2,034	2,238	2,695	2,567	-

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.